Raaj Medisafe board meets May 29 to consider FY26 results
Raaj Medisafe India Limited's board meeting on May 29, 2026, will focus on approving the audited financial results for Q4 and FY26, along with financial statements and cash flow reports. The agenda also includes approving related party transactions, authorizing the conversion of physical shares to demat form, and reviewing governance reports for the quarter ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
Raaj Medisafe India Limited has announced that its board of directors will meet on May 29, 2026, to discuss and approve the company's financial performance for the fiscal year ending March 31, 2026. The meeting is scheduled to take place at 3:00 P.M. at the company's registered office in Ujjain.
Agenda for the Meeting
The primary focus of the meeting will be the consideration and approval of the audited financial results for the quarter and year ended March 31, 2026. The board will also review the financial statements and cash flow statements for the same period. Furthermore, the directors will take note of the draft auditors' report on the financial statements.
Other Key Business Items
In addition to the financial results, the board will consider and approve transactions with related parties entered into during the period from October 1, 2025, to March 31, 2026. The meeting will also cover the adoption of the Integrated (Finance) Report, which includes details on related party transactions and the utilization of funds raised through preferential allotment.
Governance and Compliance
The board is set to authorize the Registrar and Transfer Agents (RTA) to facilitate the conversion of physical shares into dematerialized form as per a SEBI circular dated January 30, 2026. Other agenda items include adopting the Reconciliation of Share Capital Audit and reviewing the Shareholding Pattern and Integrated (Governance) Report for the quarter ended March 31, 2026.
Historical Stock Returns for Raaj Medisafe
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | +10.99% | +8.33% | -5.59% | +527.59% |
How might Raaj Medisafe India's FY2026 financial results compare to industry peers in the medical devices and pharmaceutical packaging sector, and what growth trajectory could investors expect going forward?
What are the potential implications of the related party transactions from October 2025 to March 2026 on the company's corporate governance ratings and minority shareholder confidence?
How could the SEBI-mandated conversion of physical shares to dematerialized form impact the company's shareholder base composition and future trading liquidity on the exchange?


































